Ads
    Related paper
  1. STRUCTURE BASED DRUG DESIGN METHOD: MOLECULAR DOCKING STUDY ON ANDROGENIC RECEPTOR AND PROSTATE SPECIFIC ANTIGEN WITH POTENTIAL LEAD MOLECULES
  2. In-Silico ADMET Prediction, Structure-Based Drug Design and Molecular Docking Studies of Quinazoline Derivatives as Novel EGFR Inhibitors
  3. Design of novel tazarotene derivatives as potential antipsoriatic drugs: physicochemical properties study and molecular docking analysis of their binding to retinoic acid receptor family (RAR-alpha, RAR-beta and RAR-gamma)
  4. Computer aided drug design through molecular docking: Identification of selective COX-2 inhibitorsas potential NSAIDs
  5. Transrectal Ultrasound Guided Biopsy of Prostate in Patients with Raised Serum Prostate Specific Antigen - A Histopathological Study
  6. ESTIMATION OF SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVEL IN BENIGN PROSTATE HYPERPLASIA PATIENTS AND ITS CORRELATION WITH AGE AND PROSTATE VOLUME
  7. INCIDENTAL PROSTATE CANCER IN TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) SPECIMENS HAVING INTERMEDIATE SERUM PROSTATE-SPECIFIC ANTIGEN (PSA) LEVEL
  8. STRUCTURE BASED DOCKING STUDIES TOWARDS EXPLORING POTENTIAL ANGIOTENSIN-I RECEPTOR BLOCKERS OF SELECTED ALANGIUM SALVIFOLIUM PHYTOCHEMICALS AGAINST PROTECTIVE VASCULAR REMODELING
  9. In Silico Study of Metoclopramide as A Small Molecule of Dopamine D2 Receptor: a Quantum-Mechanical (QM) Based Molecular Docking Treatment
  10. DYNAMICS OF PROSTATE-SPECIFIC ANTIGEN AFTER COMBINED RADIOTHERAPY FOR PROSTATE CANCER WITH DIFFERENT DOSE BRACHYTHERAPY